412 related articles for article (PubMed ID: 26556407)
21. The evolving role of mass spectrometry in cancer biomarker discovery.
Wang P; Whiteaker JR; Paulovich AG
Cancer Biol Ther; 2009 Jun; 8(12):1083-94. PubMed ID: 19502776
[TBL] [Abstract][Full Text] [Related]
22. Power of proteomics and progress in precision medicine - 13th central and eastern European proteomic conference (CEEPC), Ustroń, Poland.
Gadher SJ; Widlak P; Kovarova H
Expert Rev Proteomics; 2020 May; 17(5):335-340. PubMed ID: 32510255
[TBL] [Abstract][Full Text] [Related]
23. HepatoProteomics: applying proteomic technologies to the study of liver function and disease.
Diamond DL; Proll SC; Jacobs JM; Chan EY; Camp DG; Smith RD; Katze MG
Hepatology; 2006 Aug; 44(2):299-308. PubMed ID: 16871559
[TBL] [Abstract][Full Text] [Related]
24. Single cell proteomics analysis of drug response shows its potential as a drug discovery platform.
Straubhaar J; D'Souza A; Niziolek Z; Budnik B
Mol Omics; 2024 Jan; 20(1):6-18. PubMed ID: 37681418
[TBL] [Abstract][Full Text] [Related]
25. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications.
Asleh K; Riaz N; Nielsen TO
J Exp Clin Cancer Res; 2022 Sep; 41(1):265. PubMed ID: 36050786
[TBL] [Abstract][Full Text] [Related]
27. The status of proteomics as we enter the 2020s: Towards personalised/precision medicine.
Nice EC
Anal Biochem; 2022 May; 644():113840. PubMed ID: 32745541
[TBL] [Abstract][Full Text] [Related]
28. Advances in proteomic strategies toward the early detection of lung cancer.
Hassanein M; Rahman JS; Chaurand P; Massion PP
Proc Am Thorac Soc; 2011 May; 8(2):183-8. PubMed ID: 21543799
[TBL] [Abstract][Full Text] [Related]
29. Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment.
Haga Y; Minegishi Y; Ueda K
Cancer Sci; 2023 May; 114(5):1783-1791. PubMed ID: 36661476
[TBL] [Abstract][Full Text] [Related]
30. Mass cytometry and type 1 diabetes research in the age of single-cell data science.
Rahman AH; Homann D
Curr Opin Endocrinol Diabetes Obes; 2020 Aug; 27(4):231-239. PubMed ID: 32618635
[TBL] [Abstract][Full Text] [Related]
31. [Proteomic-driven precision medicine research in hepatocellular carcinoma].
Jiang Y; He FC
Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):797-802. PubMed ID: 36207935
[TBL] [Abstract][Full Text] [Related]
32. Experimental Null Method to Guide the Development of Technical Procedures and to Control False-Positive Discovery in Quantitative Proteomics.
Shen X; Hu Q; Li J; Wang J; Qu J
J Proteome Res; 2015 Oct; 14(10):4147-57. PubMed ID: 26051676
[TBL] [Abstract][Full Text] [Related]
33. Role and challenges of proteomics in pharma and biotech: technical, scientific and commercial perspective.
Qoronfleh MW
Expert Rev Proteomics; 2006 Apr; 3(2):179-95. PubMed ID: 16608432
[TBL] [Abstract][Full Text] [Related]
34. [Contribution of proteomic analysis to study cardiovascular physiopathology].
Dupont A; Pinet F
Ann Biol Clin (Paris); 2005; 63(6):611-7. PubMed ID: 16330379
[TBL] [Abstract][Full Text] [Related]
35. Biomarker discovery and applications for foods and beverages: proteomics to nanoproteomics.
Agrawal GK; Timperio AM; Zolla L; Bansal V; Shukla R; Rakwal R
J Proteomics; 2013 Nov; 93():74-92. PubMed ID: 23619387
[TBL] [Abstract][Full Text] [Related]
36. Recent developments in proteome informatics for mass spectrometry analysis.
Wright JC; Hubbard SJ
Comb Chem High Throughput Screen; 2009 Feb; 12(2):194-202. PubMed ID: 19199887
[TBL] [Abstract][Full Text] [Related]
37. Clinical proteomics: present and future prospects.
Verrills NM
Clin Biochem Rev; 2006 May; 27(2):99-116. PubMed ID: 17077880
[TBL] [Abstract][Full Text] [Related]
38. Cancer proteomics: developments in technology, clinical use and commercialization.
Yeat NC; Lin C; Sager M; Lin J
Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
[TBL] [Abstract][Full Text] [Related]
39. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
[TBL] [Abstract][Full Text] [Related]
40. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
